EVerZom
Biotech · Strasbourg, FR
Terapie a base di esosomi da cellule staminali mesenchimali per la medicina rigenerativa.
Funding history
| Date | Round | Amount |
|---|
| Oct 2025 | Funding round EVerZom raised €10 million to start the first clinical trial of EVerGel against Crohn's perianal fistulas in 2026. | $11.6M |
Investors
Aloe Private EquityCapital CellCapital Grand EstEIC FundParis Business AngelsSorbonne Venture by Audacia
Similar companies in Biotech
Explore funding flow on EquityFlow →